Plain-English translation of NCT03781115 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Researchers are testing whether and —two common antipsychotic medications—can help create a fast, affordable way to diagnose schizophrenia. The study measures how your brain responds to a single dose of one of these medications using a brain-wave test called an EEG. The hope is that people with schizophrenia will show a different pattern on this test compared to people without the condition.
Currently, diagnosing schizophrenia can take a long time and involves many steps. Researchers want to develop a simple, quick test that could help doctors identify the condition earlier and more affordably.
You will take a single dose of one of two antipsychotic medications, and then researchers will measure your brain activity using an EEG (a painless test that reads electrical signals from your brain). For people with schizophrenia, the study first confirms that you have not taken certain medications recently, or are newly diagnosed and unmedicated. The study involves a physical exam, questionnaires, heart rhythm testing, and a urine drug screen to make sure it's safe for you to participate.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
United States